|
|
||||||||
Nuclear Medicine Department, William Beaumont Hospital, Royal Oak, Michigan
Correspondence: For reprints contact: Cheryl M. Culver, MS, Nuclear Medicine Department, William Beaumont Hospital, 3601 West Thirteen Mile Rd., Royal Oak, MI 48072.
ABSTRACT
The purpose of this study was to develop guidelines based on patient measurements as to when iodine-131- (131I) treated hyperthyroid patients may resume close personal contact. External exposure rates were measured on 59 patients using an ionization survey meter in the upright position. The initial measurement was recorded within 20 min post-dose administration at one meter. Exposure rates were measured 211 days post-dose administration at 1, 0.6, and 0.3 meters from the patient's thyroid. In the administered dose range of 3 to less than 12 mCi of 131I, all 40 patients measured
2.0 mR/hr at one meter on Day 0, and 25 patients (25/29) were
2.0 mR/hr at 0.6 meter on Days 24. Guidelines can be prepared based on the administered dose that are rational and in conformity with existing radiologic health standards.
This article has been cited by other articles:
![]() |
P. W. Grigsby, B. A. Siegel, S. Baker, and J. O. Eichling Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma JAMA, May 3, 2000; 283(17): 2272 - 2274. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Herman and S. O'Neill Breastfeeding after Radionuclide Administration J Hum Lact, September 1, 1995; 11(3): 223 - 227. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |